Significantly upregulated pathways in GDM placentae included several immune responses (IL-2, TNFα, IFNγ, IL-6, TGF-β) and downregulation of glycolysis and cell cycle pathways (Fig. 4g). This evidence concerns the gene TGFB1 and gestational diabetes.